Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (branded as HY Pharma / Zhejiang Hongyuan Pharmaceutical) is a Chinese pharmaceutical company established in 2005, now a subsidiary of the Wuchan Zhongda Group (Fortune 500). The company focuses on cardiovascular and hypoglycemic drug substance, API, and finished dosage form development and manufacturing, with 21+ invention patents.
cardiovascular APIs, hypoglycemic drugs, small molecule API manufacturing, pharmaceutical intermediates
1 site worldwide
No reviews available yet.
No documents available.